Key result
In patients with type 2 diabetes mellitus without clinical evidence of macrovascular disease, increased arterial stiffness measured by ba-PWV was independently associated with subclinical myocardial injury (β = 0.25).
Why the study?
Is arterial stiffness associated with subclinical myocardial injury in patients with type 2 diabetes mellitus without overt macrovascular disease?
Population
100 patients with type 2 diabetes mellitus without clinical evidence of macrovascular disease and 150 age…
Design
Cross-sectional
Authors
Loading...
Arterial stiffness may mark subclinical myocardial injury in T2DM; hypothesis-generating and requires prospective validation before clinical use.
Cross-Sectional (n=250)
No
Is arterial stiffness associated with subclinical myocardial injury in patients with type 2 diabetes mellitus without overt macrovascular disease?
Effect estimate: β = 0.25 (95% CI 0.04-1.18)
p-value: p=0.04
Increased arterial stiffness, measured by brachial-ankle pulse wave velocity, is independently associated with subclinical myocardial injury in patients with type 2 diabetes mellitus without overt macrovascular disease.
Yiu et al. (2013) conducted a cross-sectional in Type 2 diabetes mellitus (n=250). Arterial stiffness (ba-PWV) was evaluated on Independent association of brachial-ankle pulse wave velocity (ba-PWV) with high-sensitivity troponin I (hs-TnI) in patients with T2DM (β = 0.25, 95% CI 0.04-1.18, p=0.04). In patients with type 2 diabetes mellitus without clinical evidence of macrovascular disease, increased arterial stiffness measured by ba-PWV was independently associated with subclinical myocardial injury (β = 0.25).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: